# Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)

> **NCT01669980** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 40 (actual)

## Conditions studied

- Infections
- Pneumonia

## Interventions

- **DRUG:** Ceftaroline fosamil
- **DRUG:** IV Ceftriaxone and Vancomycin

## Key facts

- **NCT ID:** NCT01669980
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-05
- **Final completion:** 2014-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01669980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01669980, "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01669980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*